Registro:

Referencias:

• Hibi, M., Nakajima, K., Hirano, T., IL-6 cytokine family and signal transduction: A model of the cytokine system (1996) J Mol Med, 74, pp. 1-12
• Kishimoto, T., Taga, T., Akira, S., Cytokine signal transduction (1994) Cell, 76, pp. 253-262
• Kishimoto, T., Akira, S., Narazaki, M., Taga, T., Interleukin-6 family of cytokines and gp130 (1995) Blood, 86, pp. 1243-1254
• Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway (1998) Biochem J, 334, pp. 297-314
• Ohmichi, M., Hirota, K., Koike, K., Kurachi, H., Ohtsuka, S., Matsuzaki, N., Yamaguchi, M., Tanizawa, O., Binding sites for interleukin-6 in the anterior pituitary gland (1992) Neuroendocrinology, 55, pp. 199-203
• Akita, S., Webster, J., Ren, S.G., Takino, H., Said, J., Zand, O., Melmed, S., Human and murine pituitary expression of leukemia inhibitory factor. Novel intra-pituitary regulation of adrenocorticotropin hormone synthesis and secretion (1995) J Clin Invest, 95, pp. 1288-1298
• Auernhammer, C.J., Melmed, S., Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis (1999) Endocrinology, 140, pp. 1559-1566
• Perez Castro, C., Carbia Nagashima, A., Páez-Pereda, M., Goldberg, V., Chervin, A., Largen, P., Renner, U., Arzt, E., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753
• Arzt, E., Gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuro-endocrine pathways (2001) J Clin Invest, 108, pp. 1729-1733
• Busquet, C., Zatelli, M.C., Melmed, S., Direct regulation of pituitary pro-opiomelanocortin by STAT3 provides a novel mechanism for immunoneuroendocrine interfacing (2000) J Clin Invest, 106, pp. 1417-1425
• Auernhammer, C.J., Melmed, S., The central role of SOCS-3 in integrating the neuro-immunoendocrine interface (2001) J Clin Invest, 108, pp. 1735-1740
• Spangelo, B.L., Judd, A.M., Isakson, P.C., MacLeod, R.M., Interleukin-6 stimulates anterior pituitary hormone release in vitro (1989) Endocrinology, 127, pp. 575-577
• Spangelo, B.L., Gorospe, W.C., Role of the cytokines in the neuroendocrine-immune system axis (1995) Front Neuroendocrinol, 16, pp. 1-12
• Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocr Rev, 18, pp. 206-228
• Arzt, E., Páez-Pereda, M., Perez Castro, C., Pagotto, U., Rennet, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front Neuroendocrinol, 20, pp. 71-95
• Auernhammer, C.J., Melmed, S., Leukemia-inhibitory factor-neuroimmune modulator of endocrine function (2000) Endocr Rev, 21, pp. 313-345
• Páez-Pereda, M., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Chervín, A., Arzt, E., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Exp Clin Endocr Diabetes, 108, pp. 202-207
• Perez Castro, C., Nagashima, A.C., Páez-Pereda, M., Goldberg, V., Chervín, A., Carrizo, G., Molina, H., Arzt, E., Effects of the gp130 cytokines CNTF and IL-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of PRL and GH secretion in normal rat anterior pituitary aggregate cultures (2001) J Endocrinol, 169, pp. 539-547
• Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Stalla, G.K., Interleukin involvement in anterior pituitary cell growth regulation: Effects of interleukin-2 (IL-2) and IL-6 (1993) Endocrinology, 132, pp. 459-467
• Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for TtT/GF mouse pituitary cells (1997) Exp Clin Endocrinol Diabetes, 105, pp. 345-352
• Sawada, T., Koike, K., Kanda, Y., Ikegami, H., Jikihara, T., Maeda, T., Osako, Y., Miyake, A., Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro (1995) J Endocrinol Invest, 18, pp. 83-90
• Koyama, C., Matsumoto, H., Sakai, T., Wakabayashi, K., Ito, A., Couch, E.F., Inoue, K., Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice (1995) Endocr Pathol, 6, pp. 67-75
• Páez-Pereda, M., Goldberg, V., Chervín, A., Carrizo, G., Molina, A., Andrada, J., Sauer, J., Arzt, E., Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants (1996) Mol Cell Endocrinol, 124, pp. 33-42
• Saito, M., Yoshida, K., Hibi, M., Taga, T., Kishimoto, T., Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo (1992) J Immunol, 148, pp. 4066-4071
• Wen, Z., Zhong, Z., Darnell, J.J., Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation (1995) Cell, 82, pp. 241-250
• Williams, C., Baer, M., Dillner, A., Johnson, P., CRP2 (c/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation. DNA binding and cell specificity (1995) EMBO J, 14, pp. 3170-3183
• Farrow, K.N., Manning, N., Schaufele, F., Gutierrez-Hartmann, A., The c-Jun γ-domain inhibits neuroendocrine promoter activity in a DNA sequence and pituitary-specific manner (1996) J Biol Chem, 271, pp. 17139-17146
• Tanuma, N., Nakamura, K., Shima, H., Kikuchi, K., Protein-tyrosine phosphatase PTPεC inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells (2000) J Biol Chem, 275, pp. 28216-28221
• Arzt, E., Stelzer, G., Renner, U., Lange, M., Müller, O.A., Stalla, G.K., Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures (1992) J Clin Invest, 90, pp. 1944-1951
• Starr, R., Willson, T.A., Viney, E.M., Murray, L.J.L., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Hilton, D.J., A family of cytokine-inducible inhibitors of signaling (1997) Nature, 387, pp. 917-921
• Arzt, E., Sauer, J., Pollmacher, T., Labeur, M., Holsboer, F., Reul, J.M.H.M., Stalla, G.K., Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin (1994) Endocrinology, 134, pp. 672-677
• Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G., Retinoic acid prevents experimental Cushing syndrome (2001) J Clin Invest, 108, pp. 1123-1131
• Asa, S.L., Ezzat, S., The cytogenesis and pathogenesis of pituitary adenomas (1998) Endocr Rev, 19, pp. 798-827
• Melmed, S., Acromegaly and cancer: Not a problem? (2001) J Clin Endocrinol Metab, 86, pp. 2929-2934
• Pei, L., Melmed, S., Isolation and characterization of a pituitary tumor-transforming gene (PTTG) (1997) Mol Endocrinol, 11, pp. 433-441
• Horiguchi, A., Oya, M., Marumo, K., Murai, M., STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P (2002) Kidney Int, 61, pp. 926-938
• Liu, X.H., Kirschenbaum, A., Lu, M., Yao, S., Klausner, A., Preston, C., Holland, J.F., Levine, A.C., Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway (2002) Biochem Biophys Res Commun, 290, pp. 249-255
• Campbell, C.L., Jiang, Z., Savarese, D.M., Savarese, T.M., Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma (2001) Am J Pathol, 158, pp. 25-32
• Burger, R., Guenther, A., Bakker, F., Schmalzing, M., Bernand, S., Baum, W., Duerr, B., Gramatzki, M., Gp130 and ras mediated signaling in human plasma cell line INA-6: A cytokine-regulated tumor model for plasmacytoma (2001) Hematol J, 2, pp. 42-53
• Gloddek, J., Pagotto, U., Páez-Pereda, M., Arzt, E., Stalla, G.K., Rennet, U., Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells (1999) J Endocrinol, 160, pp. 483-490
• Leung, C.K.H., Shiu, P.C., Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice (1981) Cancer Res, 41, pp. 546-551
• Yano, T., Uozumi, T., Kawamoto, K., Mukada, K., Onda, J., Ito, A., Fujimoto, N., Photodynamic therapy for rat pituitary tumor in vitro and in vivo using pheophorbide-A and white light (1991) Lasers Surg Med, 11, pp. 174-182
• Davalli, A.M., Galbiati, F., Bertuzzi, F., Polastri, L., Pontiroli, A.E., Perego, L., Freschi, M., Meoni, C., Insulin-secreting pituitary GH3 cells: A potential β-cell surrogate for diabetes cell therapy (2000) Cell Transplant, 9, pp. 841-851
• Nakashima, K., Taga, T., Gp130 and IL-6 family of cytokines: Signaling mechanisms and thrombopoietic activities (1998) Semin Hematol, 35, pp. 210-221
• Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Daisuke, M., Hamaguchi, M., Davis, S., Kishimoto, T., Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130 (1992) Proc Natl Acad Sci USA, 89, pp. 10998-11001
• Tone, E., Kunisawa, K., Kumanogoh, A., Negoro, S., Funamoto, M., Osugi, T., Kishimoto, T., Yamauchi-Takihara, K., Gp130-dependent signaling pathway is not enhanced in gp130 transgenic heart after LIF stimulation (2000) Cytokine, 12, pp. 1512-1518

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------